Rejuvenating dysfunctional T cells in ovarian cancer: CD28 is the license to kill.

Cancer Cell

Department of Medicine, Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Parker Institute for Cancer Immunotherapy at MSK, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address:

Published: December 2021

High-grade serous ovarian cancers (HGSOCs) exhibit limited response to immune checkpoint blockade. In a new study in Cancer Cell, Duraiswamy et al. highlight intratumoral CD28 co-stimulation by myeloid-antigen-presenting cells as a key mechanism required for activation of programmed cell death receptor 1 (PD-1) tumor-infiltrating T lymphocytes during PD-1 blockade in HGSOC.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2021.10.011DOI Listing

Publication Analysis

Top Keywords

rejuvenating dysfunctional
4
dysfunctional t cells
4
t cells ovarian
4
ovarian cancer
4
cancer cd28
4
cd28 license
4
license kill
4
kill high-grade
4
high-grade serous
4
serous ovarian
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!